Experience

Davis Polk advised the joint lead managers on a Regulation S offering by Xi’an Aerospace High-Tech Industry Development Co., Ltd, a company incorporated in the People’s Republic of China…

Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,500,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $400 million aggregate principal amount of its 1.000%…

Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 865,963 shares of common stock for an aggregate price to the public of approximately $143.75 million,…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Silicon Laboratories Inc. of $535 million aggregate principal amount of its…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Applied Materials, Inc. of $750 million aggregate principal amount of its 1.750% notes due 2030 and $750…

Davis Polk advised CenterState Bank Corporation on its $200 million SEC-registered fixed-to-floating-rate subordinated notes due 2030. CenterState is a financial holding company which,…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 103,500,000 units of Foley Trasimene Acquisition Corp., including…